Komipharm International Co., Ltd. (KOSDAQ:041960)

Market Cap	290.27B
Revenue (ttm)	54.53B
Net Income (ttm)	11.34B
Shares Out	69.28M
EPS (ttm)	164.14
PE Ratio	25.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84,327
Average Volume	105,490
Open	4,230.00
Previous Close	4,230.00
Day's Range	4,170.00 - 4,275.00
52-Week Range	3,610.00 - 4,940.00
Beta	-0.67
RSI	62.53
Earnings Date	Mar 14, 2025

About Komipharm International

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. The company manufactures veterinary drugs in injectable, powder, oral solution, topical solution, disinfectant, and other forms. It is also developing anticancer drugs and cancer pain-relieving agents for human health and life. In addition, the company also engages in clinical pathological experiment, test, and analysis activities. The company was formerly known as Korea Microbiological...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1972
• Employees: 158
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041960

Financial Performance

In 2023, Komipharm International's revenue was 42.65 billion, an increase of 7.15% compared to the previous year's 39.80 billion. Losses were -3.98 billion, -38.91% less than in 2022.